A ubiquitin independent degradation pathway utilized by a Hepatitis B virus envelope protein to limit antigen presentation

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Liu, Yuanjie ^a   Testa, James S ^b   Philip, Ramila ^b   Block, Timothy M ^a   Mehta, Anand S ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b Immunotope Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VIRUS ENVELOPE PROTEIN; HEPATITIS B VIRUS M PROTEIN; LYSINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; POLYMER; PROTEASOME; UBIQUITIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; ISOPROTEIN; PEPTIDE; POLYSACCHARIDE;

ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM ASSOCIATED DEGRADATION; HUMAN; HUMAN CELL; PROTEIN DEGRADATION; PROTEIN TRANSPORT; QUALITY CONTROL; SIGNAL TRANSDUCTION; UBIQUITINATION; CELL STRAIN HEK293; CHEMISTRY; CYTOSOL; CYTOTOXIC T LYMPHOCYTE; HEPATITIS B VIRUS; LYSOSOME; METABOLISM; PROTEIN PROCESSING;

HEPATITIS B VIRUS;

ANTIGEN PRESENTATION; CYTOSOL; HEK293 CELLS; HEPATITIS B VIRUS; HUMANS; LYSOSOMES; PEPTIDES; POLYSACCHARIDES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOLYSIS; T-LYMPHOCYTES, CYTOTOXIC; UBIQUITIN; UBIQUITINATION; VIRAL ENVELOPE PROTEINS;

EID: 80053288136     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024477     Document Type: Article

References (65)

1. Molinari M, (2007) N-glycan structure dictates extension of protein folding or onset of disposal. Nat Chem Biol 3: 313-320.
2. Vembar SS, Brodsky JL, (2008) One step at a time: endoplasmic reticulum-associated degradation. Nat Rev Mol Cell Biol 9: 944-957.
3. Feldman M, van der Goot FG, (2009) Novel ubiquitin-dependent quality control in the endoplasmic reticulum. Trends Cell Biol 19: 357-363.
4. Helenius A, Trombetta ES, Herbert DN, Simons JF, (1997) Calnexin, calreticulin and the folding of glycoproteins. Trends Cell Biol 7: 193-200.
5. Ou WJ, Cameron PH, Thomas DY, Bergeron JJ, (1993) Association of folding intermediates of glycoproteins with calnexin during protein maturation. Nature 364: 771-776.
6. Sifers RN, (2009) Defining the ERAD connection: assembly required. Cell Cycle 8: 4026-4027.
7. Nakatsukasa K, Brodsky JL, (2008) The recognition and retrotranslocation of misfolded proteins from the endoplasmic reticulum. Traffic 9: 861-870.
8. Cascio P, Hilton C, Kisselev AF, Rock KL, Goldberg AL, (2001) 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide. EMBO J 20: 2357-2366.
9. Kikkert M, Hassink G, Barel M, Hirsch C, van der Wal FJ, et al. (2001) Ubiquitination is essential for human cytomegalovirus US11-mediated dislocation of MHC class I molecules from the endoplasmic reticulum to the cytosol. Biochem J 358: 369-377.
10. Shamu CE, Flierman D, Ploegh HL, Rapoport TA, Chau V, (2001) Polyubiquitination is required for US11-dependent movement of MHC class I heavy chain from endoplasmic reticulum into cytosol. Mol Biol Cell 12: 2546-2555.
11. Jarosch E, Taxis C, Volkwein C, Bordallo J, Finley D, et al. (2002) Protein dislocation from the ER requires polyubiquitination and the AAA-ATPase Cdc48. Nat Cell Biol 4: 134-139.
12. Yu H, Kopito RR, (1999) The role of multiubiquitination in dislocation and degradation of the alpha subunit of the T cell antigen receptor. J Biol Chem 274: 36852-36858.
13. Ye Y, Meyer HH, Rapoport TA, (2003) Function of the p97-Ufd1-Npl4 complex in retrotranslocation from the ER to the cytosol: dual recognition of nonubiquitinated polypeptide segments and polyubiquitin chains. J Cell Biol 162: 71-84.
14. Gerlich WH, Heermann KH, Lu X, (1992) Functions of hepatitis B surface proteins. Arch Virol Suppl 4 pp. 129-132.
15. Thung SN, Gerber MA, Kasambalides EJ, Gilja BK, Keh W, et al. (1986) Demonstration of pre-S polypeptides of hepatitis B virus in infected livers. Hepatology 6: 1315-1318.
16. Lin JH, Walter P, Yen TS, (2008) Endoplasmic reticulum stress in disease pathogenesis. Annual review of pathology 3: 399-425.
17. Yeung P, Wong DK, Lai CL, Fung J, Seto WK, et al. (2011) Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in chronic hepatitis B. The Journal of infectious diseases 203: 646-654.
18. Huang HP, Hsu HY, Chen CL, Ni YH, Wang HY, et al. (2010) Pre-S2 deletions of hepatitis B virus and hepatocellular carcinoma in children. Pediatric research 67: 90-94.
19. Abe K, Thung SN, Wu HC, Tran TT, Le Hoang P, et al. (2009) Pre-S2 deletion mutants of hepatitis B virus could have an important role in hepatocarcinogenesis in Asian children. Cancer science 100: 2249-2254.
20. Fang ZL, Sabin CA, Dong BQ, Wei SC, Chen QY, et al. (2008) Hepatitis B virus pre-S deletion mutations are a risk factor for hepatocellular carcinoma: a matched nested case-control study. J Gen Virol 89: 2882-2890.
21. Wang HC, Huang W, Lai MD, Su IJ, (2006) Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis. Cancer Sci 97: 683-688.
22. Wang HC, Chang WT, Chang WW, Wu HC, Huang W, et al. (2005) Hepatitis B virus pre-S2 mutant upregulates cyclin A expression and induces nodular proliferation of hepatocytes. Hepatology 41: 761-770.
23. Hsieh YH, Su IJ, Wang HC, Chang WW, Lei HY, et al. (2004) Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis 25: 2023-2032.
24. Wang HC, Wu HC, Chen CF, Fausto N, Lei HY, et al. (2003) Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress. Am J Pathol 163: 2441-2449.
25. Fan YF, Lu CC, Chen WC, Yao WJ, Wang HC, et al. (2001) Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection. Hepatology 33: 277-286.
26. Mangold CM, Streeck RE, (1993) Mutational analysis of the cysteine residues in the hepatitis B virus small envelope protein. J Virol 67: 4588-4597.
27. Lord JM, Deeks E, Marsden CJ, Moore K, Pateman C, et al. (2003) Retrograde transport of toxins across the endoplasmic reticulum membrane. Biochem Soc Trans 31: 1260-1262.
28. Heiligenstein S, Eisfeld K, Sendzik T, Jimenez-Becker N, Breinig F, et al. (2006) Retrotranslocation of a viral A/B toxin from the yeast endoplasmic reticulum is independent of ubiquitination and ERAD. EMBO J 25: 4717-4727.
29. Katiyar S, Li G, Lennarz WJ, (2004) A complex between peptide:N-glycanase and two proteasome-linked proteins suggests a mechanism for the degradation of misfolded glycoproteins. Proc Natl Acad Sci U S A 101: 13774-13779.
30. Suzuki T, Park H, Hollingsworth NM, Sternglanz R, Lennarz WJ, (2000) PNG1, a yeast gene encoding a highly conserved peptide:N-glycanase. J Cell Biol 149: 1039-1052.
31. Ye Y, Meyer HH, Rapoport TA, (2001) The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol. Nature 414: 652-656.
32. Kothe M, Ye Y, Wagner JS, De Luca HE, Kern E, et al. (2005) Role of p97 AAA-ATPase in the retrotranslocation of the cholera toxin A1 chain, a non-ubiquitinated substrate. J Biol Chem 280: 28127-28132.
33. Musti AM, Treier M, Bohmann D, (1997) Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases. Science 275: 400-402.
34. Yoshida Y, Tanaka K, (2010) Lectin-like ERAD players in ER and cytosol. Biochim Biophys Acta 1800 pp. 172-180.
35. Christianson JC, Shaler TA, Tyler RE, Kopito RR, (2008) OS-9 and GRP94 deliver mutant alpha1-antitrypsin to the Hrd1-SEL1L ubiquitin ligase complex for ERAD. Nat Cell Biol 10: 272-282.
36. Liu YC, (2004) Ubiquitin ligases and the immune response. Annu Rev Immunol 22: 81-127.
37. Yewdell J, Anton LC, Bacik I, Schubert U, Snyder HL, et al. (1999) Generating MHC class I ligands from viral gene products. Immunol Rev 172: 97-108.
38. Huang L, Marvin JM, Tatsis N, Eisenlohr LC, (2011) Selective role of ubiquitin in MHC class I antigen presentation. J Immunol 186: 1904-1908.
39. Grant EP, Michalek MT, Goldberg AL, Rock KL, (1995) Rate of antigen degradation by the ubiquitin-proteasome pathway influences MHC class I presentation. J Immunol 155: 3750-3758.
40. Mellman I, Cresswell P, (2010) Antigen processing and presentation. Curr Opin Immunol 22: 78-80.
41. Golovina TN, Morrison SE, Eisenlohr LC, (2005) The impact of misfolding versus targeted degradation on the efficiency of the MHC class I-restricted antigen processing. J Immunol 174: 2763-2769.
42. Karttunen J, Sanderson S, Shastri N, (1992) Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proc Natl Acad Sci U S A 89: 6020-6024.
43. Karttunen J, Shastri N, (1991) Measurement of ligand-induced activation in single viable T cells using the lacZ reporter gene. Proc Natl Acad Sci U S A 88: 3972-3976.
44. Liu Y, Simsek E, Norton P, Sinnathamby G, Philip R, et al. (2007) The role of the downstream signal sequences in the maturation of the HBV middle surface glycoprotein: development of a novel therapeutic vaccine candidate. Virology 365: 10-19.
45. Norton PA, Menne S, Sinnathamby G, Betesh L, Cote PJ, et al. (2010) Glucosidase inhibition enhances presentation of de-N-glycosylated hepatitis B virus epitopes by major histocompatibility complex class I in vitro and in woodchucks. Hepatology 52: 1242-1250.
46. Wang J, Michalak TI, (2006) Inhibition by woodchuck hepatitis virus of class I major histocompatibility complex presentation on hepatocytes is mediated by virus envelope pre-S2 protein and can be reversed by treatment with gamma interferon. J Virol 80: 8541-8553.
47. Levrero M, Pollicino T, Petersen J, Belloni L, Raimondo G, et al. (2009) Control of cccDNA function in hepatitis B virus infection. J Hepatol 51: 581-592.
48. Summers J, Smith PM, Huang MJ, Yu MS, (1991) Morphogenetic and regulatory effects of mutations in the envelope proteins of an avian hepadnavirus. J Virol 65: 1310-1317.
49. Lenhoff RJ, Summers J, (1994) Coordinate regulation of replication and virus assembly by the large envelope protein of an avian hepadnavirus. J Virol 68: 4565-4571.
50. Seeger C, Mason WS, (2000) Hepatitis B virus biology. Microbiology and molecular biology reviews: MMBR 64: 51-68.
51. Eisenlohr LC, Huang L, Golovina TN, (2007) Rethinking peptide supply to MHC class I molecules. Nat Rev Immunol 7: 403-410.
52. Myung J, Kim KB, Crews CM, (2001) The ubiquitin-proteasome pathway and proteasome inhibitors. Med Res Rev 21: 245-273.
53. Yuksek K, Chen WL, Chien D, Ou JH, (2009) Ubiquitin-independent degradation of hepatitis C virus F protein. J Virol 83: 612-621.
54. Shimizu Y, Okuda-Shimizu Y, Hendershot LM, (2010) Ubiquitylation of an ERAD substrate occurs on multiple types of amino acids. Molecular cell 40: 917-926.
55. Verma R, Oania R, Graumann J, Deshaies RJ, (2004) Multiubiquitin chain receptors define a layer of substrate selectivity in the ubiquitin-proteasome system. Cell 118: 99-110.
56. Gnann A, Riordan JR, Wolf DH, (2004) Cystic fibrosis transmembrane conductance regulator degradation depends on the lectins Htm1p/EDEM and the Cdc48 protein complex in yeast. Mol Biol Cell 15: 4125-4135.
57. Yu H, Kaung G, Kobayashi S, Kopito RR, (1997) Cytosolic degradation of T-cell receptor alpha chains by the proteasome. J Biol Chem 272: 20800-20804.
58. Lilley BN, Ploegh HL, (2004) A membrane protein required for dislocation of misfolded proteins from the ER. Nature 429: 834-840.
59. Sun F, Zhang R, Gong X, Geng X, Drain PF, et al. (2006) Derlin-1 promotes the efficient degradation of the cystic fibrosis transmembrane conductance regulator (CFTR) and CFTR folding mutants. J Biol Chem 281: 36856-36863.
60. Ellgaard L, Frickel EM, (2003) Calnexin, calreticulin, and ERp57: teammates in glycoprotein folding. Cell Biochem Biophys 39: 223-247.
61. Molinari M, Calanca V, Galli C, Lucca P, Paganetti P, (2003) Role of EDEM in the release of misfolded glycoproteins from the calnexin cycle. Science 299: 1397-1400.
62. Kimura Y, Nakazawa M, Yamada M, (1998) Cloning and characterization of three isoforms of OS-9 cDNA and expression of the OS-9 gene in various human tumor cell lines. J Biochem 123: 876-882.
63. Graham FL, Smiley J, Russell WC, Nairn R, (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. The Journal of general virology 36: 59-74.
64. Simsek E, Sinnathamby G, Block TM, Liu Y, Philip R, et al. (2009) Inhibition of cellular alpha-glucosidases results in increased presentation of hepatitis B virus glycoprotein-derived peptides by MHC class I. Virology 384: 12-15.
65. Sinnathamby G, Lauer P, Zerfass J, Hanson B, Karabudak A, et al. (2009) Priming and activation of human ovarian and breast cancer-specific CD8+ T cells by polyvalent Listeria monocytogenes-based vaccines. J Immunother 32: 856-869.